title: Construct validity of negative symptoms: an empirical and conceptual review.
abstract: The construct validity of negative symptoms is reviewed, and findings on deficit negative symptoms are also incorporated. A valid negative symptom construct should: (a) have replicable relationships with observable phenomena and other constructs; (b) have good reliability, temporal stability, and homogeneity; and (c) predict prognosis and response to treatment, possess convergent and discriminant validity, and be useful to clinicians. Although a number of well-replicated findings provide support for the validity of the construct, modification is warranted. Specifically, the data suggest that there is a highly correlated set of negative symptoms, which includes flat affect, alogia, anhedonia, and avolition. Primary and enduring symptoms from this set have good predictive and discriminant validity and can be studied in the context of the deficit syndrome, as well as with current negative symptom rating scales. Future studies should examine whether deficit negative symptoms are better conceptualized as a dimension or a category, elucidate the relationship between deficit symptoms and additional clinical and behavioral variables (e.g., response to newer neuroleptic medications and diminished emotional responding), and explore differences between the pattern of correlates of deficit symptoms and those of the positive and thought disorder symptoms.
authors.affiliation: Department of Psychology, Vanderbilt University, Nashville, TN 37240, USA.
authors.forename: K S
authors.initials: KS
authors.lastname: Earnst
authors.forename: A M
authors.initials: AM
authors.lastname: Kring
mesh_terms: D001921:Brain / Q000002:abnormalities / Q000378:metabolism; D006801:Humans; D009483:Neuropsychological Tests; D018377:Neurotransmitter Agents / Q000502:physiology; D015203:Reproducibility of Results; D012559:Schizophrenia / Q000175:diagnosis* / Q000378:metabolism; D012565:Schizophrenic Psychology; D013997:Time Factors
chemical_list: D018377:Neurotransmitter Agents